Tackling airborne infection risk

Viroklenz Medairsan technology allows activation of powerful biocides within the airflow of the machine. The smaller machine has been designed for use at the patient’s bedside and a larger wall-mounted unit for use in communal areas. Each of these units contains a biodegradable refill impregnated with a biocide formulation that is unique to Viroklenz. The biocides are proven to kill known pathogens, including MRSA, Avian Influenza H5N1, C.difficile and many others.

The system has been designed to run continuously with an in-built warning sensor which lights up when the refill needs changing, approximately every six weeks. There is no potential harm to patients or staff working in the area as the biocides have passed rigorous safety criteria and no biocides are released into the atmosphere.

Astudy conducted by the University of Bath found that the MRSA “superbug” has evolved in order to side step some protection measures. Scientists found the bug on inanimate objects such as vases, sinks and walls. As amoebae produce cysts to help them spread, this could mean that MRSA may be able to be “blown in the wind” between different locations.